Congratulations, Sebastian!

In a new publication on childhood medullobastoma in Lancet Oncology we propose criteria for routine genetic screenings based on clinical and molecular tumour characteristics. Please also see the feature on the EMBL webpage here. This work resulted from a large international collaboration with researchers  e.g. from St. Jude Children’s Research Hospital in Memphis, and Hopp Children’s Cancer Center at the NCT Heidelberg (KiTZ).